Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew site revision entry 'Revision: v3.3.3' was added to the history and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer; these are maintenance updates that do not affect the study content.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdded system revision v3.3.2 and removed revision v3.2.0.SummaryDifference0.1%

- Check55 days agoChange DetectedThe funding/operating-status banner was removed from the page. Core study details remain unchanged.SummaryDifference0.8%

- Check69 days agoChange DetectedA new version (2022-10-17) updates the study's recruitment status to terminated due to enrollment difficulties and consideration of clinical guidelines. The record history lists the version and its changes.SummaryDifference0.1%

- Check98 days agoChange DetectedSummary: The page now displays a status/operational notice and a version upgrade to v3.2.0, replacing the prior v3.1.0. Key impact is to inform users about current operating status and where to check details.SummaryDifference13%

- Check105 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.